LLY vs MVIS · P/E 39, rev $22.97B vs rev $2.4M
Eli Lilly and Company (LLY) versus Microvision Inc (MVIS) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Microvision Inc (MVIS) is a scientific & technical instruments company listed on US.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported MVIS revenue for 2026-06-30 was $2.4M. Net income was -$62.2M. MVIS currently screens at market cap $200.4M.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. MVIS currently screens at market cap $200.4M.
Not investment advice. Open the LLY and MVIS stock pages for the full models.
Not investment advice.